| Name | Sonepcizumab |
|---|
| Description | Sonepcizumab (LT 1009) is a fully humanized anti-S1P monoclonal antibody. Sonepcizumab has the potential for the research of metastatic renal cell carcinoma (mRCC)[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |